MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2025 International Congress

    Health Disparity in Rural Southern California

    A. Maleki, M. Tar, D. Tar (moreno valley, USA)

    Objective: To analyze the demographic and clinical characteristics of hispanic patients with Parkinson's disease in rural southern California Background: Parkinson’s disease (PD) is the second…
  • 2025 International Congress

    The Role of Knowledgeable Informants in the Early Detection of Parkinson’s Disease

    E. Trinh, K. Harrison, M. Korell, C. Meng, E. Brown, K. Comyns, X. Chen, M. Bock, L. Racelo, G. Stebbins, C. Tanner (San Francisco, USA)

    Objective: To investigate the reporting of changes observed by Knowledgeable Informants (KIs) and people with Parkinson’s disease (PwPD) prior to a Parkinson’s disease (PD) diagnosis.…
  • 2025 International Congress

    Pesticide Exposure and Parkinson’s Disease Motor Subtype

    D. Thordarson, J. Bronstein, A. Keener, B. Ritz, K. Paul (Los Angeles, USA)

    Objective: The present study aims to investigate the link between Parkinson’s disease (PD) motor subtype and PD-relevant pesticide exposures. Background: PD is a neurodegenerative disorder…
  • 2025 International Congress

    Clinical Characteristics of Parkinsons Disease and their Role in Differential Diagnosis

    M. Ganieva, L. Tolibova (Dushanbe, Tajikistan)

    Objective: To study and systematize the clinical characteristics of Parkinson's disease (PD) and their role in differential diagnosis with other parkinsonian syndromes. Background: Parkinson’s disease…
  • 2025 International Congress

    A Biomarker-Directed Approach to the Early Diagnosis of Parkinson’s Disease Using Artificial Intelligence and Machine Learning

    ME. Mellaci (SÃO PAULO, Brazil)

    Objective: The main purpose of this study was to assess how AI and ML methods integrate multiple biomarkers for diagnosing Parkinson’s Disease (PD) to improve…
  • 2025 International Congress

    Establishing a Timeline of Non-Motor and Motor Symptoms Progression in Parkinson’s Disease Using a Sub-Chronic MPTP Mouse Model

    M. Chopra, A. Sekar, R. Hussain, L. Diwakar (Bengaluru, India)

    Objective: Parkinson’s disease (PD) mouse model using 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) was explored for pathological mechanisms driving non-motor symptoms (NMS). Aim was to map the behavioural changes…
  • 2025 International Congress

    Unveiling the Molecular Mechanism of Polydatin in Ameliorating Parkinson’s Disease via the DRD2/CRYAB/NF-κB Axis in Astrocytes and Exploring Cell Therapy Strategies

    SJ. Peng, LP. Wang, YJ. Ou, RE. Liu (Beijing, China)

    Objective: Define polydatin's therapeutic mechanism targeting astrocyte-mediated neuroinflammation in Parkinson's disease (PD) and assess combinatorial efficacy with dopamine progenitor transplantation. Background: PD progression involves substantia…
  • 2025 International Congress

    Neural Correlates of Rhythmic Auditory Stimulation Responsiveness in Parkinson’s Disease: A Pilot Gait and fMRI Study

    CY. Chien, CL. Lin, JSK. Chang, YH. Liu, SC. Wang, CC. Lin (Tainan, Taiwan)

    Objective: To compare neural activity differences between Parkinson's disease patients responsive to rhythmic auditory stimulation (RAS-r) and those not responsive (RAS-n) using functional MRI (fMRI).…
  • 2025 International Congress

    Levodopa mediated normalization of cerebello-thalamo-cortical GABA and Glutamate in Parkinson’s disease

    S. Prasad, D. Deelchand, M. Kumar, R. Yadav, P. Pal, J. Saini (Bengaluru, India)

    Objective: This study aims to evaluate the effect of levodopa on cerebello-thalamo-cortical (CTC) gamma-aminobutyric acid (GABA) and glutamate in patients with Parkinson’s disease (PD) using…
  • 2025 International Congress

    Exploring the Association between Autonomic Responses and Dopaminergic Pathways in Early Parkinson’s Disease

    E. Garasto, A. Stefani, M. Pierantozzi, N. Mercuri, A. Chiaravalloti, C. Rocchi (Rome, Italy)

    Objective: To assess if cardiovascular dysautonomia, evaluated by autonomic function tests (AFTs), is related to dopaminergic nicgrostriatal loss and other non-motor symptoms in early Parkinson…
  • « Previous Page
  • 1
  • …
  • 64
  • 65
  • 66
  • 67
  • 68
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley